INDSWFTLTD — Ind Swift Share Price
0.000.00%
Last trade - 00:00- IN₹1.12bn
- IN₹10.63bn
- IN₹5.02bn
- 28
- 82
- 65
- 64
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.24 | ||
| EV to EBITDA | 22.04 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.41% | ||
| Return on Equity | n/a | ||
| Operating Margin | 4.26% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 3,295.2 | 3,560.59 | 3,977.14 | 4,109.58 | 5,022.48 | n/a | n/a | 11.68% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ind Swift Limited is an India-based pharmaceutical manufacturing and marketing company. The Company operates in both domestic and export markets. It is primarily engaged in the finished goods dosage and active pharmaceutical ingredients (APIs) and herbal products. The Company is also engaged in the hand sanitizer, face mask and personal protective equipment (PPE) kit market. It operates through various divisions, such as Noble Division, Nova Division, Ethical Division, Generic Division, Institution Division and Proposed Division. Its Noble Division produces various products, such as Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin and Stemin Forte. The Company also provides a range of COVID19 products, including masks, travel kits, hand sanitizers, and gloves. It has also launched two products, Stevia (natural sweetener) and Hangover (helps avoid alcoholic hangover). The Company also has five plants in India.
Directors
- Sanjeev Mehta CHM (57)
- Gopal Munjal CEO (53)
- N. Munjal NVC (69)
- Amit Tarafder VFN
- Vikrant Mehta MDR (56)
- Amrender Yadav SEC
- B. Padha DRC
- Atul Saxena DRC
- V. Arora NED
- Himanshu Jain NED (31)
- Rishav Mehta NED
- Jagvir Ahluwalia IND
- Subhash Galhotra IND
- Jatender Kakkar IND
- Poonam Maini IND
- Anoop Michra IND
- R. Bedi NID (54)
- H. P. S. Chawla NID (73)
- S. Mathur NID (56)
- S. Sharma NID
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- June 6th, 1986
- Public Since
- July 29th, 1994
- No. of Employees
- 1,670
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 54,164,653
- Address
- 781, Industrial Area,Phase II,, CHANDIGARH, 160002
- Web
- http://www.indswiftltd.com/
- Phone
- +91 1724680800
- Auditors
- Jain & Associates
Upcoming Events for INDSWFTLTD
Ind Swift Ltd Annual Shareholders Meeting
Q2 2025 Ind Swift Ltd Earnings Release
Similar to INDSWFTLTD
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Ind Swift share price?
As of Today at 15:20 UTC, shares in Ind Swift are trading at IN₹21.82. This share price information is delayed by 15 minutes.
How has the Ind Swift share price performed this year?
Shares in Ind Swift last closed at IN₹21.82 and the price had moved by +95.7% over the past 365 days. In terms of relative price strength the Ind Swift share price has outperformed the S&P BSE 100 Index by +49.53% over the past year.
What are the analyst and broker recommendations for Ind Swift?
There is no consensus recommendation for this security.
What is the Ind Swift dividend yield?
Ind Swift does not currently pay a dividend.
Does Ind Swift pay a dividend?
Ind Swift does not currently pay a dividend.
When does Ind Swift next pay dividends?
Ind Swift does not currently pay a dividend.
How do I buy Ind Swift shares?
To buy shares in Ind Swift you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Ind Swift?
As of the previous close price of IN₹21.82, shares in Ind Swift had a market capitalisation of IN₹1.18bn.
Where are Ind Swift shares listed?
Here are the trading details for Ind Swift:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: INDSWFTLTD
What kind of share is Ind Swift?
Based on an overall assessment of its quality, value and momentum Ind Swift is currently classified as a Turnaround. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Ind Swift share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Ind Swift share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ind Swift. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +9.54%.
As of the last closing price of IN₹21.82, shares in Ind Swift were trading +13.46% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Ind Swift PE Ratio?
The Ind Swift PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹21.82.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Ind Swift?
Ind Swift's management team is headed by:
- Sanjeev Mehta - CHM
- Gopal Munjal - CEO
- N. Munjal - NVC
- Amit Tarafder - VFN
- Vikrant Mehta - MDR
- Amrender Yadav - SEC
- B. Padha - DRC
- Atul Saxena - DRC
- V. Arora - NED
- Himanshu Jain - NED
- Rishav Mehta - NED
- Jagvir Ahluwalia - IND
- Subhash Galhotra - IND
- Jatender Kakkar - IND
- Poonam Maini - IND
- Anoop Michra - IND
- R. Bedi - NID
- H. P. S. Chawla - NID
- S. Mathur - NID
- S. Sharma - NID